Production of a thermoplastic polyurethane/silver nanoparticles 3D filament with antiviral properties to combat SARS-CoV-2

被引:1
|
作者
Agnol, Lucas Dall [1 ,2 ]
Ornaghi Jr, Heitor Luiz [2 ]
Ernzen, Juliano Roberto [1 ,2 ]
Faccio, Maira [1 ,2 ]
Bianchi, Otavio [1 ,3 ,4 ]
机构
[1] Univ Caxias Do Sul, Postgrad Program Mat Sci & Engn PGMAT, Caxias Do Sul, Brazil
[2] Mantoflex Ind Plast Ltda, Caxias Do Sul, Brazil
[3] Fed Univ Rio Grande Sul UFRGS, Inst Chem, Organ Chem Dept, Porto Alegre, Brazil
[4] Fed Univ Rio Grande Sul UFRGS, Dept Mat Engn DEMAT, Porto Alegre, Brazil
来源
POLYMER ENGINEERING AND SCIENCE | 2024年 / 64卷 / 01期
关键词
3D filament; antiviral and antibacterial activities; nanoparticles; SARS-CoV-2; TPU; SILVER NANOPARTICLES; NANOCOMPOSITE; INACTIVATION; COMPOSITES;
D O I
10.1002/pen.26534
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Antiviral agents present a propitious alternative to prevent pathogen transmission on various surfaces. In the present study, we successfully synthesized nanocomposites of thermoplastic polyurethanes with silver nanoparticles (TPU/AgNPs) via extrusion. To comprehensively evaluate their potential in antiviral applications, we conducted a thorough analysis of the nanocomposites, encompassing investigations into their chemical structure, physicochemical and mechanical properties, cytotoxicity, antibacterial activity, and antiviral efficacy. Remarkably, the incorporation of AgNPs had no discernible impact on the chemical structure of the materials, ensuring the preservation of essential properties. Moreover, the nanoparticles exhibited remarkable stability within the TPU matrix, with no detectable leaching of AgNPs observed in any of the studied nanocomposites. The nanocomposites demonstrated exceptional antibacterial efficiency, effectively inhibiting bacterial growth while concurrently revealing no cytotoxic effects in vitro for BALB/3 T3 cells. The antiviral performance against SARS-CoV-2 proved highly potent, achieving inactivation yields surpassing 99.0%. Leveraging these advantageous attributes, we harnessed the potential of TPU/AgNPs nanocomposites to produce various versatile products, such as cell phone cases and 3D-printing filaments. In conclusion, this study underscores the immense promise of antiviral TPU/AgNPs nanocomposites, offering new insights into the domains of materials science and infection control, contributing to a healthier and safer future.
引用
收藏
页码:130 / 141
页数:12
相关论文
共 50 条
  • [1] Potent antiviral effect of silver nanoparticles on SARS-CoV-2
    Jeremiah, Sundararaj S.
    Miyakawa, Kei
    Morita, Takeshi
    Yamaoka, Yutaro
    Ryo, Akihide
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (01) : 195 - 200
  • [2] Production of a sprayable waterborne polyurethane coating with silver nanoparticles for combating SARS-CoV-2
    Agnol, Lucas Dall
    Ornaghi Jr, Heitor Luiz
    Ernzen, Juliano Roberto
    Dias, Fernanda Trindade Gonzalez
    Bianchi, Otavio
    JOURNAL OF COATINGS TECHNOLOGY AND RESEARCH, 2023, 20 (06) : 1935 - 1947
  • [3] Production of a sprayable waterborne polyurethane coating with silver nanoparticles for combating SARS-CoV-2
    Lucas Dall Agnol
    Heitor Luiz Ornaghi
    Juliano Roberto Ernzen
    Fernanda Trindade Gonzalez Dias
    Otávio Bianchi
    Journal of Coatings Technology and Research, 2023, 20 : 1935 - 1947
  • [4] In vitro antiviral effect of silver nanoparticles against SARS-CoV-2
    Florez-Alvarez, Lizdany
    Hernandez, Juan C.
    Zapata, Wildeman
    Charry-Zuluaga, Jose Ivan
    Jaramillo, Jose R.
    Taborda, Natalia A.
    Gonzalez, Juan D.
    Martinez, Larry L.
    Yassin, Lina M.
    IATREIA, 2023, 36 (01) : 5 - 15
  • [5] Antiviral Properties of Silver Nanoparticles against SARS-CoV-2: Effects of Surface Coating and Particle Size
    He, Qinghao
    Lu, Jing
    Liu, Nian
    Lu, Wenqing
    Li, Yu
    Shang, Chao
    Li, Xiao
    Hu, Ligang
    Jiang, Guibin
    NANOMATERIALS, 2022, 12 (06)
  • [6] Application of Silver Nanoparticles as a New Alternative Antiviral Agent for SARS-CoV-2: A Review
    Jamunkar, Reena
    Shrivas, Kamlesh
    Sinha, Deepak
    Patel, Sanyukta
    Monisha
    Patle, Alka
    Kumar, Antresh
    Banerjee, Subhash
    CURRENT NANOSCIENCE, 2022, 18 (04) : 465 - 477
  • [7] Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
    Abbott, Timothy R.
    Dhamdhere, Girija
    Liu, Yanxia
    Lin, Xueqiu
    Goudy, Laine
    Zeng, Leiping
    Chemparathy, Augustine
    Chmura, Stephen
    Heaton, Nicholas S.
    Debs, Robert
    Pande, Tara
    Endy, Drew
    La Russa, Marie F.
    Lewis, David B.
    Qi, Lei S.
    CELL, 2020, 181 (04) : 865 - +
  • [8] Promising Repurposed Antiviral Molecules to Combat SARS-CoV-2: A Review
    Ratan, Yashumati
    Rajput, Aishwarya
    Jain, Vivek
    Mishra, Dinesh Kumar
    Gautam, Rupesh Kumar
    Pareek, Ashutosh
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023, 24 (14) : 1727 - 1739
  • [9] Synthesis and Evaluation of a Silver Nanoparticle/Polyurethane Composite That Exhibits Antiviral Activity against SARS-CoV-2
    Lam, Wing T.
    Babra, Tahkur S.
    Smith, Julian H. D.
    Bagley, Mark C.
    Spencer, John
    Wright, Edward
    Greenland, Barnaby W.
    POLYMERS, 2022, 14 (19)
  • [10] Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2
    Hussein, Mouraya
    dos Ramos, Zaria Andrade
    Vink, Monique A.
    Kroon, Pascal
    Yu, Zhenghao
    Enjuanes, Luis
    Zuniga, Sonia
    Berkhout, Ben
    Herrera-Carrillo, Elena
    VIRUSES-BASEL, 2023, 15 (03):